Nemours Biomedical Research

Vicky L. Funanage, Ph.D.

Director of Biomedical Research of the Nemours Foundation

Alfred I. duPont Hospital for Children
Nemours Biomedical Research
1600 Rockland Road
Wilmington, DE 19803

Phone: (302) 651-6819
FAX: (302) 651-6876
E-mail: vfunanag@nemours.org

Education:
Ph.D., Biological Sciences, University of Delaware, 1981
M.S., Genetics, Pennsylvania State University, 1977
B.S., Biology, Pennsylvania State University, 1975

Biography:
Dr. Funanage received a BS in biology and a Master's degree in genetics from the Pennsylvania State University in University Park, PA and a Ph.D. in Biological Sciences from the University of Delaware in Newark, DE.   Following her Ph.D. she joined Nemours in 1981 where she worked under the direction of the Chief of Microbial Genetics at the Alfred I. duPont Hospital for Children in Wilmington, Delaware.

Since 2000, she has been the Director of Biomedical Research of the Nemours Foundation. Although located in Wilmington, Dr. Funanage oversees all operating functions for the Delaware and Florida research programs and is also responsible for spearheading research partnerships and collaborative initiatives with the scientific, medical and educational communities. In addition, she is Director of Medical Research, Director of the Molecular Diagnostic Lab (genetests.org), and Chief of the Musculoskeletal Inherited Disease Research Program, at the Alfred I. duPont Hospital for Children.  She is also Associate Professor of Pediatrics at Thomas Jefferson University in Philadelphia, PA. 

Ongoing research conducted in Dr. Funanage's laboratory (Musculoskeletal Inherited Disease Laboratory [MID]) involves projects designed to provide benefit to children afflicted with neuromuscular diseases such as muscular dystrophy, spinal muscular atrophy, and myotonic dystrophy.  In addition, Dr. Funanage is involved in a number of collaborative efforts including the study of leptin, an important hormone that regulates energy metabolism and utilization and its importance in fetal and neonatal growth and development; and investigation of the genetic and biochemical basis of hypoplastic left heart syndrome.

Dr. Funanage is strongly published in peer-reviewed journals and is an editorial reviewer for six prestigious journals.  She is a member of the Alliance of Independent Academic Medical Centers, the International Society for Heart Research, the American Society for Bone and Mineral Research, the American Association for the Advancement of Science, the American Society of Human Genetics and the American Society for Cell Biology. Her committee involvement is extensive and includes the Delaware Science and Technology Council, American Heart Association Research Council, External Advisory Committees of INBRE and IGERT, and the Myotonic Dystrophy Working Group of the Muscular Dystrophy Association. She holds several patents for her research efforts, was inducted into the Phi Sigma Biological Honor Society, and most recently received the University of Delaware's Distinguished Alumnus Award for Biological Sciences. 

RECENT PRESS

Achieving great things.

2010 DHSA Research Conference Coverage
May 5, 2010--More than 275 people from the health sciences research and education community turned out for the 2010 Delaware Health Sciences Alliance Conference on Tuesday, May 4, to share research and explore issues in health care.
UD and Nemours/Alfred I. duPont Hospital to partner on bone disorder study
April 15, 2010--In search of a new treatment for the debilitating disease osteogenesis imperfecta (OI), a team of researchers from the University of Delaware and Nemours/Alfred I. duPont Hospital for Children is initiating a two-year study exploring the use of an FDA-approved vibration platform in children with OI.
Delaware Health Sciences Alliance awards two pilot projects
April 1, 2010--Two pilot projects funded by the Delaware Health Sciences Alliance (DHSA) under its second competition focus on identifying cutting-edge cancer therapies, and creating the bioinformatics framework that will facilitate translational research among the alliance members.
Transforming the Region's Healthcare
March, 2010--An article in the March edition of Select Greater Philadelphia's "Momentum" discusses how the DSHA is drawing on the collective resources of its partner members - including the health sciences campus to be developed by the University of Delaware at the former Chrysler site - to revolutionize healthcare research and education in the region.

National experts to speak at Delaware Health Sciences Alliance research conference
Tuesday, February 18, 2010--The Delaware Health Sciences Alliance (DHSA) will host its second annual research conference on May 4 at Christiana Care Health System's John H. Ammon Medical Education Center on the Christiana Hospital Campus.

UD health sciences dean to lead partnership programs
December 14, 2009--Kathy Matt, dean of the College of Health Sciences at the University of Delaware, has been appointed to leadership positions in two partnership programs that she sees as key to promoting health research and education in Delaware.
Older adults with cancer, caregivers focus of $600,000 research grant
Dec. 11, 2009--A team that includes two researchers from the University of Delaware's School of Nursing -- Paula Klemm, professor of nursing, and Veronica Rempusheski, the Jeanne K. Buxbaum Chair of Nursing Science -- has been awarded a two-year, $600,000 grant to conduct research aimed at supporting older adults affected by cancer and their caregivers in Delaware.
DHSA takes center stage at UD Trustees meeting
December 9, 2009--The University of Delaware's Board of Trustees got a firsthand look at the largest single property acquisition in the history of the institution during its semiannual meeting, held Tuesday, Dec. 8, at the former Chrysler assembly plant on South College Avenue in Newark.
Christiana Care's Dr. Petrelli to share cancer success story at national surgeons' conference
November 11, 2009--Christiana Care's pioneering role in significantly reducing Delaware's cancer rate will be in the national spotlight at a prestigious medical conference.